Cognitive assessment of children at age 2 1/2 years after maternal fish oil supplementation in pregnancy: A randomised controlled trial

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 93, Issue 1, 2008, Pages

  Dunstan, J A ^a   Simmer, K ^a   Dixon, G ^b   Prescott, S L ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; OMEGA 3 FATTY ACID; PLACEBO;

ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MEGADOSE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; PHASE 1 CLINICAL TRIAL; PREGNANCY; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VITAMIN SUPPLEMENTATION;

ADULT; CHILD DEVELOPMENT; CHILD, PRESCHOOL; COGNITION; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; HUMANS; PREGNANCY; PRENATAL NUTRITION PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; WESTERN AUSTRALIA;

EID: 38049178597     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2006.099085     Document Type: Article

References (35)

1. Clandinin MT, Chappell JE, Heim T, et al. Fatty acid accretion in fetal and neonatal liver: implications for fatty acid requirements. Early Hum Dev 1981;5:7-14.
2. Neuringer M, Connor WE, Van Petten C, et al. Dietary omega-3 fatty acid deficiency and visual loss in infant rhesus monkeys. J Clin Invest 1984;73:272-6.
3. Gibson RA, Makrides M. Polyunsaturated fatty acids and infant visual development: a critical appraisal of randomized clinical trials. Lipids 1999;34:179-84.
4. Lapillonne A, Clarke SD, Heird WC. Polyunsaturated fatty acids and gene expression. Curr Opin Clin Nutr Metab Care 2004;7:151-6.
5. Berghaus TM, Demmelmair H, Koletzko B. Fatty acid composition of lipid classes in maternal and cord plasma at birth. Eur J Pediatr 1998;157:763-8.
6. Coleman RA. The role of the placenta in lipid metabolism and transport. Semin Perinatol 1989;13:180-91.
7. Innis SM. Essential fatty acids in growth and development. Prog Lipid Res 1991;30:39-103.
8. Hornstra G, Al MD, van Houwelingen AC, et al. Essential fatty acids in pregnancy and early human development. Eur J Obstet Gynecol Reprod Biol 1995;61:57-62.
9. Helland IB, Saugstad OD, Smith L, et al. Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics 2001;108:e82.
10. Helland IB, Smith L, Saarem K, et al. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4years of age. Pediatrics 2003;111:e39-44.
11. Malcolm CA, McCulloch DL, Montgomery C, et al. Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomised trial. Arch Dis Child Fetal Neonatal Ed 2003;88:F383-90.
12. Colombo J, Kannass KN, Shaddy DJ, et al. Maternal DHA and the development of attention in infancy and toddlerhood. Child Dev 2004;75:1254-67.
13. O'Connor DL, Hall R, Adamkin D, et al. Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial. Pediatrics 2001;108:359- 71.
14. Simmer K, Patole S. Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst Rev 2004;1:CD000375.
15. Gibson RA, Chen W, Makrides M. Randomized trials with polyunsaturated fatty acid interventions in preterm and term infants: functional and clinical outcomes. Lipids 2001;36:873-83.
16. Uauy R, Hoffman DR, Mena P, et al. Term infant studies of DHA and ARA supplementation on neurodevelopment: results of randomized controlled trials. J Pediatr 2003;143:S17-25.
17. Dunstan J, Mori TA, Barden A, et al. Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomised controlled trial. J Allergy Clin Immunol 2003;112:1178-84.
18. Dunstan JA, Mori TA, Barden A, et al. Effects of n-3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. Eur J Clin Nutr 2004;58:429- 37.
19. Mori TA, Beilin LJ, Burke V, et al. Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease. Arterioscler Thromb Vasc Biol 1997;17:279-86.
20. Griffiths R. The abilities of young children. A comprehensive system of mental measurement for the first eight years of life. London, Child Development Research Centre, 1970.
21. Dunn L, Dunn L. Examiners manual for the Peabody Picture Vocabulary Test. Third edition Form IIIA and IIIB. Circle Pines, MN: American Guidance Service, 1997.
22. Achenbach TM. Manual for the Child Behaviour Checklist/1 1/2-5 and 1991 profile. Burlington, VT: University of Vermont Department of Psychiatry, 1991.
23. Dunstan JA, Mori TA, Barden A, et al. Maternal fish oil supplementation in pregnancy reduces interleukin-13 levels in cord blood of infants at high risk of atopy. Clin Exp Allergy 2003;33:442-8.
24. SanGiovanni JP, Parra-Cabrera S, Colditz GA, et al. Meta-analysis of dietary essential fatty acids and long-chain polyunsaturated fatty acids as they relate to visual resolution acuity in healthy preterm infants. Pediatrics 2000;105:1292-8.
25. Simmer K. Longchain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst Rev 2001;4:CD000376.
26. Neuringer M, Jeffrey BG. Visual development: neural basis and new assessment methods. J Pediatr 2003;143:S87-95.
27. Morale SE, Hoffman DR, Castaneda YS, et al. Duration of long-chain polyunsaturated fatty acids availability in the diet and visual acuity. Early Hum Dev 2005;81:197-203.
28. Birch EE, Hoffman DR, Castaneda YS, et al. A randomized controlled trial of long-chain polyunsaturated fatty acid supplementation of formula in term infants after weaning at 6 wk of age. Am J Clin Nutr 2002;75:570-80.
29. Williams C, Birch EE, Emmett PM, et al. Stereoacuity at age 3.5 y in children born full-term is associated with prenatal and postnatal dietary factors: a report from a population-based cohort study. Am J Clin Nutr 2001;73:316-22.
30. Cheruku SR, Montgomery-Downs HE, Farkas SL, et al. Higher maternal plasma docosahexaenoic acid during pregnancy is associated with more mature neonatal sleep-state patterning. Am J Clin Nutr 2002;76:608-13.
31. Bakker EC, Ghys AJ, Kester AD, et al. Long-chain polyunsaturated fatty acids at birth and cognitive function at 7 y of age. Eur J Clin Nutr 2003;57:89-95.
32. Ghys A, Bakker E, Hornstra G, et al. Red blood cell and plasma phospholipid arachidonic and docosahexaenoic acid levels at birth and cognitive development at 4years of age. Early Hum Dev 2002;69:83-90.
33. Malcolm CA, Hamilton R, McCulloch DL, et al. Scotopic electroretinogram in term infants born of mothers supplemented with docosahexaenoic acid during pregnancy. Invest Ophthalmol Vis Sci 2003;44:3685-91.
34. Clandinin MT, Van Aerde JE, Parrott A, et al. Assessment of the efficacious dose of arachidonic and docosahexaenoic acids in preterm infant formulas: fatty acid composition of erythrocyte membrane lipids. Pediatr Res 1997;42:819-25.
35. Dixon G, Badawi N, Kurinczuk JJ, et al. Early developmental outcomes after newborn encephalopathy. Pediatrics 2002;109:26-33.